A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Clinical trial NCT07409428 · RECRUITING

Trial details

NCT number: NCT07409428
Sponsor: Hutchmed
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Start date: 2026-03-20
Primary completion: 2028-04-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.